A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer
Abstract Lung cancer remains the leading cause of cancer deaths worldwide. Although low-dose spiral computed tomography (LDCT) screening is used for the detection of lung cancer in a high-risk population, false-positive results of LDCT remain a clinical problem. Here, we developed a blood test of a...
Main Authors: | Bing Wei, Fengxin Wu, Wenqun Xing, Haibo Sun, Chi Yan, Chengzhi Zhao, Dongqing Wang, Xiaobing Chen, Yanli Chen, Mingming Li, Jie Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-96242-6 |
Similar Items
-
A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules
by: Wenqun Xing, et al.
Published: (2021-03-01) -
A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
by: Nan Shen, et al.
Published: (2019-12-01) -
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity
by: Ruochuan Zang, et al.
Published: (2019-12-01) -
DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma
by: Yunliang Tang, et al.
Published: (2020-06-01) -
Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers
by: Rui Li, et al.
Published: (2019-09-01)